- £83.01m
- £66.39m
- £19.50m
- 82
- 24
- 78
- 68
RCS - Diaceutics PLC - Sub-optimal testing impacts on cancer patients
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/Share Incentive Plan
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/Share Incentive Plan
AnnouncementREG - Diaceutics PLC - Purchase of Shares and PDMR Shareholding
AnnouncementREG - Diaceutics PLC - Half-year Report
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/Share Incentive Plan
AnnouncementREG - Diaceutics PLC - Notice of Results and Presentations
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/Share Incentive Plan
AnnouncementREG - Diaceutics PLC - Trading Update and Notice of Results
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/Share Incentive Plan
AnnouncementREG - Diaceutics PLC - Multi-year contract with top five global pharma
AnnouncementRCS - Diaceutics PLC - New AI and ML Capabilities Enhance DXRX Platform
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/Share Incentive Plan
AnnouncementREG - Diaceutics PLC - Share Options and PDMR Shareholdings
AnnouncementREG - Diaceutics PLC - Result of AGM
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/Share Incentive Plan
AnnouncementREG - Diaceutics PLC - Exercise of Warrant & Total Voting Rights
AnnouncementREG - Diaceutics PLC - Contract Win
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/Share Incentive Plan
Announcement